Logo

Sequenom to Net $18M in Private Stock Placement; Shares Surge 14 Percent

Apr 25, 2007
NEW YORK (GenomeWeb News) — Sequenom will sell $20 million worth of its common stock to new and existing institutional investors, the company said today.
 
The company said it plans to sell 6.7 million shares for $3 apiece, a 1-cent premium over yesterday’s closing price of $2.99. Sequenom said it plans to close the sale by Friday.  
 
After deductions for expenses, Sequenom said it expects the sale to net around $18.4 million.
 
News of the placement caused shares in the stock to trade up 14.25 percent, or $.43, at $3.42 in mid-afternoon trading today.
 
Lehman Brothers and Rodman & Renshaw will act as placement agents for the transaction.

Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.